Skip to main content

Genus Capital Management Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1532385 VANCOUVER, A1

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$6,072,784
-$10,551,269 QoQ
Shares Held
48,067
-59.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#534
of 2,266 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$17,651,907
PutShares
191,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Genus Capital Management Inc. holds $47,435,252 across 7 Drug Manufacturers - General names. GILD ranks #4 (12.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 GILD
Gilead Sciences, Inc.
This page
48,067 $6,072,784

All Filings in GILD

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,072,784 48,067
2026-03-31 $16,624,053 119,280
2025-12-31 $16,690,921 135,986
2025-09-30 $20,582,286 185,426
2025-06-30 $16,856,231 152,036
2025-03-31 $20,582,352 183,689
2024-12-31 $17,651,907 191,100
2024-09-30 $6,593,177 78,640
2024-03-31 $1,943,322 26,530
2023-12-31 $8,754,345 108,065
2023-06-30 $11,690,825 151,691